Zydus Lifesciences News: Collaboration with Viwit Pharma on MRI Injectables
Monday, 16 September 2024, 00:15
Overview of the Partnership
Zydus Lifesciences, a renowned player in the healthcare landscape, has made significant strides by partnering with Viwit Pharma.
The collaboration aims to produce two essential MRI injectables that are critical for diagnostic imaging. This partnership represents a major leap towards improving clinical outcomes through better imaging technologies.
Details on MRI Injectables
- Gadobutrol Injection (Brand Name: Gadavist) is utilized for various MRI scans to improve image clarity.
- Gadoterate Meglumine Injection (Brand Name: Dotarem) also serves a similar purpose in enhancing diagnostic processes.
This exciting new venture underscores Zydus Lifesciences' commitment to innovation and patient welfare.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.